Medtech Brew Event
The theme for the next Medtech Brew is 'Innovation for medtech: clinical collaboration with business' and it will take place Thursday 23 March, at Glasshouse at Electric in Galway, from 18:30-20:30.
Speakers will include:
Dr Gerry O’Sullivan who will chair the event. He received his medical degree from the University College Cork, Ireland in 1990. After 2 years in internal medicine (MRCPI) he went into Radiology in Derriford Hospital Plymouth, UK, in 1993, transferring to St. George’s Hospital London in 1995. He passed the FRCR in 1997; and obtained CCST in 1998. He undertook a IR fellowship in the world-renowned Stanford University Medical Centre, Stanford, California under Michael Dake/Charlie Semba in 1998-1999. Dr O’Sullivan was Consultant at Rush Presbyterian St. Luke’s Chicago from 1999-2002 and has been a full time IR in Galway since 2002. Dr O’Sullivan is interested in venous disease and was the first awakened in Stanford nearly 20 years ago and has remained strong ever since. Currently Dr O’Sullivan performs about 70% venous related work. His particular interests include venous thrombolysis and thrombectomy, venous stenting, venous stent design, IVC and iliac venous reconstruction. Proctor for Cook Medical, Bard, BSCI, Aspirex.
Dr Faisal Sharif is a senior lecturer in Regenerative Medicine at NUI, Galway and a consultant Interventional Cardiologist for Galway University Hospitals. Additionally, he works with BioInnovate as its Clinical Director. His research focuses on medical devices for cardiovascular medicine and translational research on vascular biology and myocardial regeneration. Dr Sharif’s has established strong industrial–clinical partnership with incorporation of novel medical devices including optical coherence tomography, renal artery denervation and transcatheter aortic valve implantation. He was the Principal Investigator for multinational randomised clinical trial involving autologous stem cell injection in patients with heart failure. Dr Sharif also continues to pursue research on vascular wall healing post-stenting through development of novel techniques and devices. His research focuses on developing novel solutions for unmet clinical needs for cardiovascular medicine. Dr Sharif’s key area of interest is translational medicine focusing on cardiovascular clinical trials for medical devices and basic science outputs.
Declan Clarke who is CEO and Founder of Zoan BioMed which won the Emerging Medtech Company of the Year at the Irish Medtech Awards 2016 co-hosted by the Irish Medtech Association, Enterprise Ireland and IDA Ireland. Zoan BioMed is a Galway based medical device company specialising in orthobiologic scaffolds. Zoan’s primary objective is to solve the problem of porosity by delivering naturally-assembled scaffolds, conferring economic and clinical benefits, with enhanced patient welfare as their driver. Zoan have turned to nature for the blueprints of their xenogeneic bone graft substitutes and the source biomaterial is tropical marine coral. Declan is also co-founder and director of the Hatchery of Ideas, a privately resourced business innovation campus. Here he has led the commercialisation of innovations as diverse as functional foods to honey bee health.
Medtech Brew is hosted by the Irish Medtech Association and BioInnovate to facilitate:
- Exchanging ideas, networking, forming alliances for medtech growth.
- Discussing breakthroughs and challenges affecting your company's business.
- Meeting with other medtech start-ups and established companies to get feedback and input.
We will be announcing the final speakers shortly.
For all queries on the event, please call the event organiser:
Claire Gilroy, Tel: +353 1 605 1581